cho_logo_symbol_border

Clear Health Pass MDAllergyPro

Identify Allergy Triggers, Optimize Treatment, & Improve Quality of Life with Clear Health Pass MDAllergyPro

Clear Health Pass MDAllergyPro is a simple allergen-specific IgE blood test used to confirm an allergy diagnosis. This form of blood testing helps assess suspected causes of symptoms, aid in allergic/nonallergic patient management, and alter the progression of allergic disease. Clear Health Pass MDAllergyPro offers allergy panels based on region, environments, trees, grasses, weeds, and common groupings of food.

A convenient and less invasive allergy test

Clear Health Pass MDAllergyPro is done with a simple blood draw, making it more convenient and less invasive for the patient. With Clear Health Pass MDAllergyPro, providers can appropriately manage their patient’s allergy symptoms, optimize patient outcomes, improve quality of life without the pain and discomfort of a traditional allergy test. 

Prevelance of allergic rhinitis is estimated to range from as low as 9% to more than 40%

65% of patients taking nonsedating antihistamines were found to be nonallergic via IgE blood testing

30 Wall St. 8th floor New York, NY 10005

Clear Health Pass as Specifications Developer

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

Clear Health Pass Holdings, LLC  (“Clear Health Pass”) operates as a Specification Developer, developing specifications for devices distributed under its name, and is listed with the Food and Drug Administration. However, the Company does not engage in manufacturing activities.

As a Specification Developer, the Company may also arrange for the manufacturing of devices labeled with another establishment’s
name by a contract manufacturer.

The distribution of collection kits, specimen transport, marketing, test distribution, and actual testing is performed by a high-complexity Clinical Laboratory Improvement Amendments (CLIA) lab.

All testing conducted by the CLIA lab is compliant with the Centers for Medicare and Medicaid Services (CMS) CLIA Lab Amendments Act.

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Skip to content